$IGMS
IGM Biosciences Inc
PRICE
$16.3 ▼-1.57%
Extented Hours
VOLUME
233,622
DAY RANGE
15.32 - 16.56
52 WEEK
12.74 - 99.44
Key Metrics
Market Cap
447.16 M
Beta
2
Avg. Volume
409.34 K
Shares Outstanding
27.40 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-08
Next Dividend Date
Company Information
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Website: igmbio.com
HQ: 325 E Middlefield Rd Mountain View, 94043-4003 California
Related News